Feb 2019

ANTG LEADING A ‘GREEN WAVE’ IN AUSTRALIA

Our CEO and founder, Matt Cantelo has met with the business editor at The Sydney Morning Herald to discuss the future of medicinal cannabis in Australia, ANTG’s export plans and company’s current investments into research. Read the article here.

ANTG appoints new Business Operations Manager   Australian Natural Therapeutics […]

READ MORE >

ANTG’s Eve Cannabis product reveals its potential to kill or inhibit cancer cells without impacting normal cells…

READ MORE >

ANTG has listed two new THC-dominant medicinal cannabis strains on the Australian Register of Therapeutic Goods (ARTG).

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >